Data as of Apr 15
| -0.0054 / -2.52%|
The 1 analysts offering 12-month price forecasts for Cytosorbents Corp have a median target of 1.00, with a high estimate of 1.00 and a low estimate of 1.00. The median estimate represents a +379.62% increase from the last price of 0.21.
The current consensus among 1 polled investment analysts is to Buy stock in Cytosorbents Corp. This rating has held steady since April, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.